Image

Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)

Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)

Non Recruiting
All
Phase N/A

Powered by AI

Overview

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1010. Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes (Group 11-13) in Non-small Cell Lung Cancer: a Multi-center, Prospective observational Clinical Trial

Description

Patients would be evaluated whether meet the criteria as clinical stage T1 non-small Cell Lung Cancer. Then, he/she would receive lobectomy. Finally, the detailed anatomical location of group 11-13 would be recorded immediately after surgery and their metastasis pattern would be explored in the follow-up period.

Eligibility

Inclusion Criteria:

  1. Preoperative examination showed patients with clinical T1 peripheral non-small cell lung cancer (NSCLC);
  2. The lesion is located in a single lung segment or between two adjacent lung segments;
  3. Perform radical lobectomy;
  4. The preoperative examination did not reveal unresectable lymph nodes;
  5. Have not received any other tumor-related treatments (including chemotherapy, radiotherapy, targeted therapy, immunotherapy, etc.) before surgery;
  6. No malignant tumor history;
  7. No contraindications to surgery (ECOG score 0-1 points);

Exclusion Criteria:

  1. Pathology revealed patients with non-T1 stage non-small cell lung cancer (NSCLC);
  2. Radical lobectomy is not performed;
  3. Acception of any anti-tumor treatment before surgery (excluding Chinese medicine treatment);
  4. Refused to enter the group or asked to leave the group.

Study details
    Carcinoma
    Non-small Cell Lung Cancer

NCT05094882

Fudan University

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.